ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
2026 ARDC Annual Survey is now open!

The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your interaction with the ARDC and use of our national research infrastructure and services. The survey will take approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure services including Reasearch Link Australia.

We will use the information you provide to improve the national research infrastructure and services we deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research Infrastructure Strategy (NCRIS) program.

Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.

Complete the 5 min survey now by clicking on the link below.

Take Survey Now

Thank you.

  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Scheme : Postgraduate Scholarships
Research Topic : gene mapping
Clear All
Filter by Field of Research
Gene and Molecular Therapy (2)
Biochemistry and Cell Biology (1)
Cancer Cell Biology (1)
Cancer Genetics (1)
Cardiology (incl. Cardiovascular Diseases) (1)
Central Nervous System (1)
Epidemiology (1)
Genomics (1)
Haematological Tumours (1)
Medical Genetics (excl. Cancer Genetics) (1)
Medical and Health Sciences not elsewhere classified (1)
Molecular Targets (1)
Nephrology and Urology (1)
Neurology and Neuromuscular Diseases (1)
Ophthalmology (1)
Receptors and Membrane Biology (1)
Vision Science (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (19)
Filter by Status
Closed (18)
Filter by Scheme
Postgraduate Scholarships (19)
Filter by Country
Australia (1)
Filter by Australian State/Territory
VIC (1)
  • Researchers (0)
  • Funded Activities (19)
  • Organisations (13)
  • Funded Activity

    Mechanisms Of Gender Differences In Genetic Aortopathy

    Funder
    National Health and Medical Research Council
    Funding Amount
    $122,686.00
    Summary
    This project will investigate the molecular mechanisms that underly the gender differences in phenotypic expression in young adults with genetic aortopathy.
    More information
    Funded Activity

    Functional Analysis Of A Novel Mammalian Zinc-finger Centromere Protein

    Funder
    National Health and Medical Research Council
    Funding Amount
    $80,068.00
    More information
    Funded Activity

    The Importance Of RUNX3 In Preventing Gastrointestinal Diseases And Tumour Metastasis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $113,322.00
    Summary
    Stomach cancer is the second leading cause of cancer-related deaths. It is estimated that in 2010, more than 1 million people will die of stomach cancer with an increase of 19%. Studies have revealed that RUNX3 has the ability to suppress the growth of stomach cancer. However the role of RUNX3 in preventing metastasis is yet unknown. Therefore, an understanding of the factors that govern metastasis will inform the design of effective therapies to prevent mortality which is high for this disease.
    More information
    Funded Activity

    Genomic Changes In Lung Malignancy

    Funder
    National Health and Medical Research Council
    Funding Amount
    $89,699.00
    Summary
    Lung cancer is a leading cause of cancer death globally. Symptoms may not develop until disease is advanced, so it is often incurable at diagnosis. Scientific developments have greatly improved our ability to test for the changes in DNA structure and function responsible for this deadly disease and its progression. This study examines whole lung cancer genomes then uses these findings to develop safer methods for detection based on changes in DNA sequence.
    More information
    Funded Activity

    For Every Question, There Is An Answer: Application Of Genomic Sequencing And Functional Genomics For Disease Gene Discovery In Children With Orphan Phenotypes

    Funder
    National Health and Medical Research Council
    Funding Amount
    $99,682.00
    Summary
    My PhD study will look closely at the genes in a family to see what is different and whether this difference is the cause of rare health problems. I will focus on children with highly unique conditions in which intellectual disability/developmental delay is a key feature. My study is important because if I can find the exact cause of rare genetic conditions, then I hope to improve the welfare of patients and families affected by these types of conditions.
    More information
    Funded Activity

    Mechanisms Of T Cell Mediated Injury In Renal Vasculitis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $133,351.00
    Summary
    Anti-MPO glomerulonephritis (GN) is an aggressive disease causing severe and permanent injury to kidneys. This disease is thought to be due to an immune-mediated response to a protein (MPO) in neutrophils (a type of white blood cell). There is some evidence that other immune cells, CD4+ T cells, may be important in this disease. Experiments using models of anti-MPO GN will aim to define the role and mechanisms by which CD4+ T cells cause inflammation in the kidney.
    More information
    Funded Activity

    Understanding Gene-environment Interactions In Relation To Risk Of Age-related Cataract

    Funder
    National Health and Medical Research Council
    Funding Amount
    $86,514.00
    Summary
    Age-related cataract is the clouding of the lens, a leading cause of visual impairment among older persons. The burden of this common eye disease will only increase as the population ages. Besides age, other environmental and genetic risk factors that increase the risk of cataract have been identified. The aim of this research is to examine how the interplay of genes and environment contributes to age-related cataract formation, using population-based data of established studies.
    More information
    Funded Activity

    Epidemiological And Molecular Risk Factors For Diabetic Retinopathy Blindness.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $61,988.00
    Summary
    Diabetic retinopathy (DR) is the leading cause of blindness in working age adults, affecting 30% of Australians with diabetes. Patients at most risk of blindness are the focus of this project. We aim to (1) investigate why some people are more likely to develop blinding DR by looking at genetic difference between diabetic patients with and without DR; and, (2) help to understand why Indigenous Australians are so over represented in this subset of diabetic patients going blind from DR.
    More information
    Funded Activity

    The Use Of Next Generation Sequencing To Diagnose Neurogenetic Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $55,689.00
    Summary
    For two groups of neurogenetic disease, leukodystrophy and polymicrogyria, the underlying genetic cause is not known for at least 50% of cases. In these cases, patients and their families do not have access to accurate genetic counselling, prognostic information or targeted therapeutics. This study will use new genetic technologies to identify the specific genetic causes underlying these diseases. These results will improve patient care and our understanding of the disease mechanisms.
    More information
    Funded Activity

    Correction Of Friedreich Ataxia Induced Pluripotent Stem Cells By Non-viral Gene Therapy

    Funder
    National Health and Medical Research Council
    Funding Amount
    $63,270.00
    Summary
    Friedreich ataxia (FRDA) is an inherited progressive disorder of the nervous system and heart. Stem cell therapy has the potential to repair or replace damaged tissues and restore organ function in FRDA patients. The defect inherent in stem cells obtained from FRDA patients will be corrected by a gene therapy approach that will restore normal FRDA gene expression and addresses major safety concerns for the clinical use of corrected stem cells in transplantation medicine.
    More information

    Showing 1-10 of 19 Funded Activites

    • 1
    • 2
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback